Align Technology Partners with University of Bern for Oral Health Study
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 02 2026
0mins
Should l Buy ALGN?
Source: Newsfilter
Align Technology's stock rose by 3.01% and reached a 20-day high amid positive market conditions. The company announced a collaboration with the University of Bern to launch Switzerland's first oral health study, aiming to collect data from approximately 1,800 children and 1,650 adults by 2027. This innovative initiative, which includes the deployment of a mobile dental van equipped with the iTero Lumina scanner, is expected to enhance diagnostic capabilities and improve public health strategies in oral health.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALGN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALGN
Wall Street analysts forecast ALGN stock price to rise
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 190.820
Low
169.00
Averages
198.70
High
220.00
Current: 190.820
Low
169.00
Averages
198.70
High
220.00
About ALGN
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Align Technology Options Trading
- Options Selling Risk: Selling puts on Align Technology does not provide the same upside potential as owning shares, as the put seller only acquires shares if the contract is exercised, limiting their upside to a 5% annualized return unless the stock drops to $125.
- Cost Basis Analysis: If Align Technology's stock falls by 32.1%, resulting in the contract being exercised, the seller's cost basis would be $113.00 per share after commissions, meaning their profit is limited to the premium collected.
- Volatility Assessment: The trailing twelve-month volatility for Align Technology is calculated at 60%, which, when combined with fundamental analysis, can help assess whether selling the January 2028 put at the $125 strike is a worthwhile risk.
- Market Trading Dynamics: On Friday afternoon, the put volume among S&P 500 components reached 1.33 million contracts, matching call volume, indicating a higher-than-normal interest in put options, reflecting market concerns about downside risks.
See More
HSBC Upgrades Align Technology Rating
- Stock Price Increase: Align Technology (ALGN) shares rose over 2% in recent Monday trading, reflecting market optimism regarding the company's future performance, particularly following HSBC's upgrade.
- Impact of Rating Upgrade: HSBC's upgrade may attract more investor attention to Align Technology, enhancing its market liquidity and stock price stability, thereby strengthening the company's competitive position in the medical device sector.
- Positive Market Reaction: Investors responded positively to HSBC's rating adjustment, indicating increased market confidence in Align Technology, which could facilitate more capital inflow and further drive stock price appreciation.
- Strategic Implications: This rating upgrade not only enhances Align Technology's market image but may also provide funding support for future business expansion and product innovation, helping the company capture a larger share of the rapidly growing digital dentistry market.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives and future expectations for these firms.
- Market Reaction Insight: While specific company names are not disclosed, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: Investors considering buying RBLX stock should pay attention to analysts' opinions, as these insights may impact market sentiment and stock performance.
- Rating Change Transparency: Benzinga provides a comprehensive view of analyst rating changes, assisting investors in obtaining complete information to make more informed investment decisions.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific stock names are not mentioned, such rating changes typically lead to price fluctuations in the affected stocks, prompting investors to closely monitor these adjustments for portfolio optimization.
- Market Reaction Expectations: Analyst rating adjustments may trigger short-term market reactions, especially when investor sentiment is sensitive towards certain stocks, thereby impacting overall market sentiment.
- Information Access Channels: Investors can access a comprehensive view of rating changes through Benzinga's analyst ratings page, enabling them to make more informed investment decisions.
See More
Major Wall Street Rating Updates on Monday
- Robinhood Upgrade: Wolfe upgraded Robinhood from Peer Perform to Outperform to capitalize on the recent selloff due to deteriorating sentiment in the crypto ecosystem, indicating that investors should seize the buying opportunity.
- Bullish on TeraWulf and Cipher Mining: Morgan Stanley initiated coverage on TeraWulf and Cipher Mining with an Overweight rating, citing significant upside potential from attractive valuations in the bitcoin mining sector.
- Timken's New CEO Drives Growth: KeyBanc upgraded Timken from Sector Weight to Overweight with a $130 price target, primarily based on expectations that new CEO Lucian Boldea will enhance organic growth initiatives and improve margins.
- Align Technologies Brand Strength: HSBC upgraded Align Technologies from Hold to Buy, emphasizing that its strong brand presence and R&D culture are key long-term growth drivers in the orthodontics market.
See More
US Stocks Plunge as Tech Sector Leads Decline
- Tech Sector Decline: Qualcomm's (QCOM) forecast of weaker-than-expected Q2 revenue led to an over 8% drop in its stock, triggering a sell-off across the tech sector, with the Nasdaq 100 index hitting a 2.5-month low, indicating waning investor confidence in technology stocks.
- Weak Labor Market Signals: Challenger's report revealed a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest for January since 2009, while initial jobless claims rose by 22,000 to 231,000, highlighting vulnerabilities in the US labor market that could hinder economic recovery.
- Bitcoin Plunge: Bitcoin (^BTCUSD) plummeted over 12% to a 1.25-year low, reflecting deepening negative momentum in the cryptocurrency market, with approximately $2 billion flowing out of Bitcoin ETFs in the past month, signaling a decline in investor confidence.
- Earnings Season Impact: Despite 150 S&P 500 companies set to report earnings this week, market focus on economic data intensifies, with S&P 500 earnings expected to grow by 8.4% in Q4, yet overall market sentiment remains suppressed by recent economic weakness.
See More
Analysis of Align Technology Options Trading
- Options Selling Risk: Selling puts on Align Technology does not provide the same upside potential as owning shares, as the put seller only acquires shares if the contract is exercised, limiting their upside to a 5% annualized return unless the stock drops to $125.
- Cost Basis Analysis: If Align Technology's stock falls by 32.1%, resulting in the contract being exercised, the seller's cost basis would be $113.00 per share after commissions, meaning their profit is limited to the premium collected.
- Volatility Assessment: The trailing twelve-month volatility for Align Technology is calculated at 60%, which, when combined with fundamental analysis, can help assess whether selling the January 2028 put at the $125 strike is a worthwhile risk.
- Market Trading Dynamics: On Friday afternoon, the put volume among S&P 500 components reached 1.33 million contracts, matching call volume, indicating a higher-than-normal interest in put options, reflecting market concerns about downside risks.
See More
HSBC Upgrades Align Technology Rating
- Stock Price Increase: Align Technology (ALGN) shares rose over 2% in recent Monday trading, reflecting market optimism regarding the company's future performance, particularly following HSBC's upgrade.
- Impact of Rating Upgrade: HSBC's upgrade may attract more investor attention to Align Technology, enhancing its market liquidity and stock price stability, thereby strengthening the company's competitive position in the medical device sector.
- Positive Market Reaction: Investors responded positively to HSBC's rating adjustment, indicating increased market confidence in Align Technology, which could facilitate more capital inflow and further drive stock price appreciation.
- Strategic Implications: This rating upgrade not only enhances Align Technology's market image but may also provide funding support for future business expansion and product innovation, helping the company capture a larger share of the rapidly growing digital dentistry market.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives and future expectations for these firms.
- Market Reaction Insight: While specific company names are not disclosed, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: Investors considering buying RBLX stock should pay attention to analysts' opinions, as these insights may impact market sentiment and stock performance.
- Rating Change Transparency: Benzinga provides a comprehensive view of analyst rating changes, assisting investors in obtaining complete information to make more informed investment decisions.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: While specific stock names are not mentioned, such rating changes typically lead to price fluctuations in the affected stocks, prompting investors to closely monitor these adjustments for portfolio optimization.
- Market Reaction Expectations: Analyst rating adjustments may trigger short-term market reactions, especially when investor sentiment is sensitive towards certain stocks, thereby impacting overall market sentiment.
- Information Access Channels: Investors can access a comprehensive view of rating changes through Benzinga's analyst ratings page, enabling them to make more informed investment decisions.
See More
Major Wall Street Rating Updates on Monday
- Robinhood Upgrade: Wolfe upgraded Robinhood from Peer Perform to Outperform to capitalize on the recent selloff due to deteriorating sentiment in the crypto ecosystem, indicating that investors should seize the buying opportunity.
- Bullish on TeraWulf and Cipher Mining: Morgan Stanley initiated coverage on TeraWulf and Cipher Mining with an Overweight rating, citing significant upside potential from attractive valuations in the bitcoin mining sector.
- Timken's New CEO Drives Growth: KeyBanc upgraded Timken from Sector Weight to Overweight with a $130 price target, primarily based on expectations that new CEO Lucian Boldea will enhance organic growth initiatives and improve margins.
- Align Technologies Brand Strength: HSBC upgraded Align Technologies from Hold to Buy, emphasizing that its strong brand presence and R&D culture are key long-term growth drivers in the orthodontics market.
See More
US Stocks Plunge as Tech Sector Leads Decline
- Tech Sector Decline: Qualcomm's (QCOM) forecast of weaker-than-expected Q2 revenue led to an over 8% drop in its stock, triggering a sell-off across the tech sector, with the Nasdaq 100 index hitting a 2.5-month low, indicating waning investor confidence in technology stocks.
- Weak Labor Market Signals: Challenger's report revealed a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest for January since 2009, while initial jobless claims rose by 22,000 to 231,000, highlighting vulnerabilities in the US labor market that could hinder economic recovery.
- Bitcoin Plunge: Bitcoin (^BTCUSD) plummeted over 12% to a 1.25-year low, reflecting deepening negative momentum in the cryptocurrency market, with approximately $2 billion flowing out of Bitcoin ETFs in the past month, signaling a decline in investor confidence.
- Earnings Season Impact: Despite 150 S&P 500 companies set to report earnings this week, market focus on economic data intensifies, with S&P 500 earnings expected to grow by 8.4% in Q4, yet overall market sentiment remains suppressed by recent economic weakness.
See More
